High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Andrea VianelloGiovanna ArcaroBeatrice MolenaCristian TuratoFausto BraccioniLuciana PaladiniStefania VioSilvia FerraresePiera PedittoFederico GallanMarina SaettaPublished in: Therapeutic advances in respiratory disease (2019)
Short-term mortality fell to below 50% when a treatment algorithm incorporating HFNC was implemented in a group of patients with AE-IPF admitted to a RICU for ARF. Patients not responding to conventional oxygen therapy seemed to benefit from HFNC. The reviews of this paper are available via the supplementary material section.
Keyphrases
- respiratory failure
- idiopathic pulmonary fibrosis
- extracorporeal membrane oxygenation
- mechanical ventilation
- end stage renal disease
- ejection fraction
- newly diagnosed
- interstitial lung disease
- chronic kidney disease
- chronic obstructive pulmonary disease
- machine learning
- acute respiratory distress syndrome
- deep learning
- prognostic factors
- stem cells
- liver failure
- systematic review
- patient reported outcomes
- cardiovascular disease
- type diabetes
- hepatitis b virus
- coronary artery disease
- cardiovascular events
- cell therapy
- replacement therapy
- neural network